Our first special report of 2024 delivers a deep-dive analysis of the public’s perception of psychedelics—and how it has evolved over the last 50 years among the general population and healthcare community.
Comprehensive insights into perceptions of psychedelics and their use in mental and behavioral health
A compilation of data spanning surveys, historical literature and recent studies investigating attitudes toward psychedelics
Use trends and nuanced perspectives across the U.S., U.K., European Union and Australia
This report will help you understand the major developments, opportunities and risks in the marketplace, including:
A deep dive into the competitive landscape
On-label vs off-label ketamine use
Impact of out-of-pocket costs and other accessibility issues
How to bring lessons from psychedelic retreats to the medical model
Everything you need to know to understand the emerging marketplaces including: legislation, logistics and licenses.
Key information for those considering new ventures
Start-up costs and considerations
Comparisons between psychedelic and cannabis legalization
Everything you need to know to understand the business of psychedelics from history to patents, to where we are today.
